HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tae Sung Kim Selected Research

Tae Sung Kim Research Topics

Disease

49Neoplasms (Cancer)
02/2022 - 05/2002
19Inflammation (Inflammations)
03/2021 - 05/2002
18Leukemia
05/2016 - 10/2002
17Infections
02/2021 - 04/2005
11Breast Neoplasms (Breast Cancer)
01/2019 - 04/2004
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 06/2006
9Neoplasm Metastasis (Metastasis)
12/2014 - 06/2003
6Acute Promyelocytic Leukemia
11/2015 - 10/2006
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2017 - 07/2010
4Wounds and Injuries (Trauma)
12/2020 - 07/2002
4Autoimmune Diseases (Autoimmune Disease)
01/2020 - 06/2005
4Tuberculosis (Tuberculoses)
01/2019 - 09/2006
4Rheumatoid Arthritis
11/2017 - 10/2002
4Lung Diseases (Lung Disease)
10/2017 - 09/2006
4Melanoma (Melanoma, Malignant)
10/2016 - 06/2006
4Myeloid Leukemia (Leukemia, Myelocytic)
02/2008 - 10/2002
3Chronic Obstructive Pulmonary Disease (COPD)
02/2022 - 12/2016
3Papillary Thyroid Cancer
10/2021 - 03/2015
3Adenocarcinoma
10/2020 - 06/2009
3Bronchiectasis
10/2018 - 04/2005
3Communicable Diseases (Infectious Diseases)
06/2016 - 05/2002
3Septic Shock (Toxic Shock Syndrome)
07/2015 - 11/2011
3Necrosis
02/2015 - 01/2006
3Hypersensitivity (Allergy)
06/2012 - 04/2005
3Pulmonary Tuberculosis
05/2009 - 04/2004
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2009 - 10/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2006 - 06/2003
2Pancreatic Neoplasms (Pancreatic Cancer)
02/2022 - 10/2020
2Blister (Bulla)
02/2022 - 01/2010
2Atopic Dermatitis (Atopic Eczema)
02/2021 - 05/2010
2Asthma (Bronchial Asthma)
01/2019 - 05/2002
2Adenocarcinoma of Lung
01/2019 - 12/2018
2Toxic Optic Neuropathy
07/2018 - 06/2015
2Fibrosis (Cirrhosis)
10/2017 - 10/2002
2Immune System Diseases (Immune Disorders)
11/2016 - 06/2012
2Thyroid Neoplasms (Thyroid Cancer)
03/2015 - 08/2010
2Anthrax
12/2014 - 01/2014
2Crohn Disease (Crohn's Disease)
07/2014 - 06/2011
2Vasculitis (Vasculitides)
07/2014 - 06/2011
2Residual Neoplasm
12/2013 - 03/2006
2Stomach Neoplasms (Stomach Cancer)
02/2013 - 06/2006

Drug/Important Bio-Agent (IBA)

15CytokinesIBA
11/2019 - 01/2006
13Proteins (Proteins, Gene)FDA Link
02/2022 - 04/2004
10Tretinoin (Retinoic Acid)FDA LinkGeneric
03/2014 - 10/2002
9DNA (Deoxyribonucleic Acid)IBA
01/2017 - 08/2003
8Interleukin-18 (Interleukin 18)IBA
02/2015 - 06/2006
8VaccinesIBA
01/2014 - 03/2006
7AntigensIBA
01/2014 - 01/2006
6Biological ProductsIBA
02/2022 - 05/2002
6InterleukinsIBA
01/2020 - 05/2002
6Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2019 - 06/2003
6Pharmaceutical PreparationsIBA
01/2017 - 09/2006
5Therapeutic UsesIBA
12/2020 - 05/2002
5Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
11/2019 - 09/2011
5Interleukin-12 (IL 12)IBA
08/2013 - 05/2002
51,25-dihydroxyvitamin DIBA
02/2011 - 08/2003
5AcidsIBA
05/2009 - 04/2005
4Interleukin-4 (Interleukin 4)IBA
01/2017 - 03/2006
4Complementary DNA (cDNA)IBA
04/2008 - 08/2003
3Phosphotransferases (Kinase)IBA
03/2021 - 05/2006
3ErbB Receptors (EGF Receptor)IBA
10/2020 - 07/2010
3Biomarkers (Surrogate Marker)IBA
07/2019 - 01/2017
3MicroRNAs (MicroRNA)IBA
02/2017 - 06/2016
3LipidsIBA
01/2017 - 07/2013
3Immunoglobulin E (IgE)IBA
01/2017 - 04/2005
3LactonesIBA
11/2015 - 10/2002
3SesquiterpenesIBA
11/2015 - 10/2002
3Cytarabine (Cytosar-U)FDA LinkGeneric
07/2015 - 04/2008
3Virulence Factors (Pathogenicity Factors)IBA
12/2014 - 04/2008
3CeramidesIBA
07/2013 - 04/2006
3SantoninIBA
02/2011 - 01/2006
3AcetalsIBA
02/2011 - 01/2006
3AllergensIBA
05/2010 - 04/2005
3AlkaloidsIBA
08/2003 - 05/2002
2Peptides (Polypeptides)IBA
02/2021 - 01/2020
2LigandsIBA
10/2020 - 01/2019
2Immunoglobulin G (IgG)IBA
11/2019 - 01/2017
2Interleukin-10 (Interleukin 10)IBA
01/2019 - 08/2013
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 01/2017
2ChemokinesIBA
01/2019 - 11/2009
2Interleukin-1beta (Interleukin 1 beta)IBA
01/2019 - 08/2003
2Matrix Metalloproteinases (MMPs)IBA
01/2019 - 09/2009
2Interleukin-6 (Interleukin 6)IBA
01/2019 - 01/2018
2Indicators and Reagents (Reagents)IBA
10/2018 - 07/2015
2Interleukin-33IBA
11/2017 - 01/2017
2n-hexanal (hexanal)IBA
10/2017 - 12/2016
2Cadherins (E-Cadherin)IBA
10/2016 - 02/2013
2indirubinIBA
05/2016 - 10/2006
2Toll-Like Receptors (Toll-Like Receptor)IBA
07/2015 - 12/2014
2IodineIBA
03/2015 - 11/2012

Therapy/Procedure

26Therapeutics
02/2021 - 10/2002
7Drug Therapy (Chemotherapy)
01/2017 - 09/2010
4Immunotherapy
02/2022 - 01/2006
4Radiotherapy
01/2017 - 08/2010
3Decompression
02/2022 - 10/2008
3Aftercare (After-Treatment)
11/2019 - 10/2008
3Neoadjuvant Therapy
01/2019 - 01/2012
2Thyroidectomy
10/2021 - 08/2015
2Traction
10/2018 - 09/2012
2Nerve Block (Nerve Blocks)
09/2014 - 08/2011